Latest news with #MAUI
Yahoo
31-07-2025
- Business
- Yahoo
Maui secures $14m in Series D to support imaging technology
Maui Imaging has secured $14m in a Series D financing round, including equity funding, for supporting the manufacturing, sales, and marketing efforts of its computed echo tomography (CET)-based imaging technology. Acertara Acoustic Laboratories spearheaded the funding round. The CET leverages ultrasound to penetrate tissues, enabling quick imaging of the human body. It is protected by more than 160 patents. The company is now advancing to the commercial stage with devices being delivered to initial users. Acertara has taken the lead in pre-orders and holds exclusive distributorship rights in the US for hospitals not served directly by Maui Imaging. Acertara Acoustic Labs president and CEO Levi Moore said: 'The MAUI ultrasound system represents a major advancement in medical imaging. By reducing the complexity of image acquisition and offering an intuitive approach, it expands ultrasound's reach to new users and clinical settings. 'We're working closely with MAUI to accelerate adoption in hospitals nationwide, where this technology has the potential to save lives and significantly improve patient outcomes.' In October 2023, the MAUI K3900 ultrasound imaging system secured 510(k) clearance from the US Food and Drug Administration (FDA). It is designed for a wide range of diagnostic applications, including abdominal, foetal, paediatric, and cardiac imaging. Maui Imaging's diagnostic imaging approach offers a blend of ultrasound and CT capabilities without the risks associated with ionising radiation. The company leverages algorithms that process the reflected energy from different angles and compile the information to generate accurate images of the body's interior. This method allows the imaging system to incorporate common impediments such as bone, gas, fat, medical instruments, and implants into the final image, rather than allowing them to hinder the imaging process. Maui Imaging is actively conducting clinical trials with military partners and other organisations to validate this technology. Last year, Maui Imaging came out of stealth mode, announcing a $4m deal with the US Department of Defense to support trauma response initiatives using its ultrasound device. This deal involved the MAUI K3900 system. "Maui secures $14m in Series D to support imaging technology" was originally created and published by Medical Device Network, a GlobalData owned brand. The information on this site has been included in good faith for general informational purposes only. It is not intended to amount to advice on which you should rely, and we give no representation, warranty or guarantee, whether express or implied as to its accuracy or completeness. You must obtain professional or specialist advice before taking, or refraining from, any action on the basis of the content on our site. Sign in to access your portfolio
Business Insider
29-07-2025
- Business
- Business Insider
Father-son startup MAUI Imaging raises $14 million to transform ultrasound technology. Read its pitch deck.
Medical startup MAUI Imaging announced Tuesday it has raised $14 million in Series D funding to develop ultrasound technology that can glimpse beyond traditional devices. While ultrasounds are mostly used for soft tissue, MAUI says it's developing a system to see through and around traditional barriers like bone, gas, fat, instruments, and implants. The company aims to expedite diagnosis and treatment, particularly in trauma scenarios, given that this kind of imaging typically requires CT or MRI scans. A father-son duo founded MAUI — an acronym for Multiple Aperture Ultrasound Insonification — out of their Silicon Valley garage in 2006. The late Don Specht started developing the technology while building space telescopes at Lockheed Martin, and sought — alongside his son David, a former Air Force flyer-turned-entrepreneur who serves as MAUI's CEO — to apply it to the human body. "We had to wait for Moore's Law to catch up," David Specht said of MAUI's long developmental road. The company emerged from stealth in August 2024 with a $4 million Department of Defense contract to study its applications in the field. The military is particularly interested in using the portable system for trauma assessment by corpsmen or medics with minimal training, Specht said. "They're trying to move the decision-making point as far forward as possible because they don't have enough doctors," Specht said. He added that MAUI's imaging results in a massive trove of data that could be useful for AI health tools. MAUI counts eight employees and eight consultants, and it has raised roughly $40 million to date. The Series D included equity funding and was led by ultrasound device company Acertara, which now has exclusive distribution rights to the system. The average sales price for the system is $85,000, plus maintenance costs, Specht said. While the FDA has cleared the device for traditional ultrasound uses, MAUI — which has 160 patents — will use data gleaned from its clinical trials with the military as it seeks clearance to make claims about seeing through and around obstructions. Here's a look at the pitch deck MAUI Imaging used to raise its $14 million Series D. Some slides and details have been redacted in order to share the deck publicly. MAUI Imaging MAUI Imaging MAUI Imaging MAUI Imaging MAUI Imaging MAUI Imaging MAUI Imaging MAUI Imaging MAUI Imaging MAUI Imaging MAUI Imaging MAUI Imaging MAUI Imaging MAUI Imaging MAUI Imaging
